p.57 抽出テキスト
180. Marrouche NF, Beheiry S, Tomassoni G, et al. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol. 2002;39:1046–54. 181. Callans DJ, Ren JF, Schwartzman D, et al. Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography. J Am Coll Cardiol. 1999;33:1667–70. 182. Frankel DS, Lin D, Anastasio N, et al. Frequent additional tachyarrhythmias in patients with inappropriate sinus tachycardia undergoing sinus node modification: an important cause of symptom recurrence. J Cardiovasc Electrophysiol. 2012;23:835–9. 183. Takemoto M, Mukai Y, Inoue S, et al. Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and long-term clinical outcome. Intern Med. 2012;51:357–62. 184. Koplan BA, Parkash R, Couper G, et al. Combined epicardial-endocardial approach to ablation of inappropriate sinus tachycardia. J Cardiovasc Electrophysiol. 2004;15:237–40. 185. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–9. 186. Steinbeck G, Hoffmann E. ‘True’ atrial tachycardia. Eur Heart J. 1998; 19 Suppl E:E48–9. 187. Wren C. Incessant tachycardias. Eur Heart J. 1998;19 Suppl E:E54–9. 188. Medi C, Kalman JM, Haqqani H, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791–7. 189. Tang CW, Scheinman MM, Van Hare GF, et al. Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol. 1995;26:1315–24. 190. Kistler PM, Roberts-Thomson KC, Haqqani HM, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol. 2006;48:1010–7. 191. Liu X, Dong J, Ho SY, et al. Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights. J Am Coll Cardiol. 2010;56:796–804. 192. Morton JB, Sanders P, Das A, et al. Focal atrial tachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics. J Cardiovasc Electrophysiol. 2001;12:653–9. 193. Kistler PM, Sanders P, Hussin A, et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol. 2003;41:2212–9. 194. Gonzalez MD, Contreras LJ, Jongbloed MRM, et al. Left atrial tachycardia originating from the mitral annulus-aorta junction. Circulation. 2004;110: 3187–92. 195. Ouyang F, Ma J, Ho SY, et al. Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation. J Am Coll Cardiol. 2006;48:122–31. 196. Roberts-Thomson KC, Kistler PM, Haqqani HM, et al. Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol. 2007;18:367–72. 197. Walters TE, Kistler PM, Kalman JM. Radiofrequency ablation for atrial tachycardia and atrial flutter. Heart Lung Circ. 2012;21:386–94. 198. Lee G, Sanders P, Kalman JM. Catheter ablation of atrial arrhythmias: state of the art. Lancet. 2012;380:1509–19. 199. Markowitz SM, Nemirovksy D, Stein KM, et al. Adenosine-insensitive focal atrial tachycardia: evidence for de novo micro-re-entry in the human atrium. J Am Coll Cardiol. 2007;49:1324–33. 200. Engelstein ED, Lippman N, Stein KM, et al. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation. 1994;89:2645–54. 201. Cossú SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: clinical and electrophysiologic characteristics. Prog Cardiovasc Dis. 1998;41:51–63. 202. Goya M, Iesaka Y, Takahashi A, et al. Radiofrequency catheter ablation for sinoatrial node reentrant tachycardia: electrophysiologic features of ablation sites. Jpn Circ J. 1999;63:177–83. 203. Saoudi N, Cosío F, Waldo A, et al. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 2001;22:1162–82. 204. Gillette PC, Garson A Jr. Electrophysiologic and pharmacologic charac- teristics of automatic ectopic atrial tachycardia. Circulation. 1977;56:571–5. 205. Mehta AV, Sanchez GR, Sacks EJ, et al. Ectopic automatic atrial tachy- cardia in children: clinical characteristics, management and follow-up. J Am Coll Cardiol. 1988;11:379–85. 206. Eidher U, Freihoff F, Kaltenbrunner W, et al. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol. 2006;29:358–62. 207. Markowitz SM, Stein KM, Mittal S, et al. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol. 1999;10:489–502. 208. Reisinger J, Gstrein C, Winter T, et al. Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. Am J Emerg Med. 2010;28:159–65. 209. Kunze KP, Kuck KH, Schlüter M, et al. Effect of encainide and flecainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol. 1986;7:1121–6. 210. Creamer JE, Nathan AW, Camm AJ. Successful treatment of atrial tachycardias with flecainide acetate. Br Heart J. 1985;53:164–6. 211. von Bernuth G, Engelhardt W, Kramer HH, et al. Atrial automatic tachycardia in infancy and childhood. Eur Heart J. 1992;13:1410–5. 212. Lucet V, Do Ngoc D, Fidelle J, et al. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases]. Arch Mal Coeur Vaiss. 1987;80:1385–93. 213. Heusch A, Kramer HH, Krogmann ON, et al. Clinical experience with propafenone for cardiac arrhythmias in the young. Eur Heart J. 1994;15:1050–6. 214. Janousek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Am J Cardiol. 1998;81:1121–4. 215. Colloridi V, Perri C, Ventriglia F, et al. Oral sotalol in pediatric atrial ectopic tachycardia. Am Heart J. 1992;123:254–6. 216. Guccione P, Paul T, Garson A Jr. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol. 1990;15:1118–24. 217. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980;100:1063–9. 218. Miyazaki A, Ohuchi H, Kurosaki K, et al. Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease. Circ J. 2008;72:1998–2003. 219. Kang KT, Etheridge SP, Kantoch MJ, et al. Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:664–70. 220. Kothari SA, Apiyasawat S, Asad N, et al. Evidence supporting a new rate threshold for multifocal atrial tachycardia. Clin Cardiol. 2005;28:561–3. 221. Yokoshiki H, Mitsuyama H, Watanabe M, et al. Swallowing-induced multifocal atrial tachycardia originating from right pulmonary veins. J Electrocardiol. 2011;44:395.e1–5. 222. Marchlinski FE, Miller JM. Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man. Chest. 1985;88:931–4. 223. Wang K, Goldfarb BL, Gobel FL, et al. Multifocal atrial tachycardia. Arch Intern Med. 1977;137:161–4. 224. Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest. 1991;99:1415–20. 225. Iseri LT, Fairshter RD, Hardemann JL, et al. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. 1985;110:789–94. 226. Kastor JA. Multifocal atrial tachycardia. N Engl J Med. 1990;322:1713–7. 227. Hazard PB, Burnett CR. Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes. Chest. 1987;91:68–70. 228. Mukerji V, Alpert MA, Diaz-Arias M, et al. Termination and suppression of multifocal atrial tachycardia with verapamil. South Med J. 1987;80:269–70. 229. Arsura EL, Solar M, Lefkin AS, et al. Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med. 1987;15:591–4. 230. Hazard PB, Burnett CR. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med. 1987;15:20–5. 231. Kouvaras G, Cokkinos DV, Halal G, et al. The effective treatment of multifocal atrial tachycardia with amiodarone. Jpn Heart J. 1989;30:301–12. 232. Levine JH, Michael JR, Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med. 1985;312:21–5. 233. Salerno DM, Anderson B, Sharkey PJ, et al. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med. 1987;107:623–8. Downloaded from http://ahajournals.org by on October 7, 2026